CJC-1295 No DAC (5mg)

What is CJC-1295 No DAC (5mg)

CJC-1295 No DAC, commonly referred to as Modified GRF (1-29), is a synthetic analogue of growth hormone-releasing hormone (GHRH) studied for its interaction with GHRH receptors and growth hormone signalling pathways.

Unlike CJC-1295 with DAC, the No DAC form does not contain the albumin-binding Drug Affinity Complex, giving it a shorter-acting profile. Research into the No DAC form focuses on GHRH signalling and endogenous growth hormone release, although direct human clinical evidence remains limited.

Why people use it

CJC-1295 No DAC is typically chosen by researchers looking to:

• Study growth hormone signalling pathways
• Investigate GHRH receptor activity
• Explore GH and IGF-1 related mechanisms
• Research short-acting GHRH analogue activity

Quality & Trust

• Third-party lab tested
• High purity compounds
• Discreet shipping
• Batch-controlled quality

Disclaimer

For research purposes only. Not intended for human consumption